Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
[X]Other congenital malformation syndromes due to known exogenous causes |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Congenital malformation caused by cytotoxic agents (disorder) |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal benzodiazepine syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal captopril/enalapril syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal carbamazepine syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal cocaine syndrome (disorder) |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal minoxidil syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal misoprostol syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal primidone syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal toluene syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal valproate syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Thalidomide embryopathy syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
embryopathie causée par l'acide rétinoïque |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal warfarin syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal methyl mercury syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal trimethadione syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal hydantoin syndrome |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
fœtus ou nouveau-né affecté par l'usage maternel d'alcool |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
fœtus ou nouveau-né affecté par le transfert placentaire ou mammaire d'alcool |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
A teratologic disorder associated with intrauterine exposure of phenobarbital during the first trimester of pregnancy. Infants are usually asymptomatic but an increased risk of intellectual disability, tetralogy of Fallot, unilateral cleft lip, hypoplasia of the mitral valve and some other mild abnormalities such as hypertelorism, epicanthus, hypoplasia and low insertion of the nose, low insertion of the ears, prognathism, finger hypoplasia, brachydactyly and hypospadias have been reported in rare cases. |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Indomethacin embryofetopathy refers to the manifestations that may be observed in a fetus or newborn when the mother has taken indomethacin, a potent prostaglandin inhibitor and tocolytic agent that can cross placenta, during pregnancy. Reported adverse fetal/neonatal effects include decreased renal function resulting in oligohydramnios, closure of the ductus arteriosus, and delayed cardiovascular adaptation at birth. These effects are usually transient and reversible. Indomethacin may also be a risk factor for cerebral injury (periventricular leukomalacia) and necrotizing enterocolitis in preterm infants. |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Fetal iodine syndrome refers to symptoms and signs that may be observed in a fetus or newborn when the mother was exposed during pregnancy to inappropriate (insufficient or excessive) amounts of iodine. Iodine deficiency is associated with goiter and hypothyroidism. When severe iodine deficiency occurs during pregnancy, it is associated with congenital hypothyroidism that is manifested by increased neonatal morbi-mortality and severe mental dysfunction, hyperactivity, attention disorders and a substantial decrease of IQ of an irreversible nature. Excessive iodine ingestion during the third trimester of pregnancy can result in hypothyroidism and fetal goiter due to a prolonged inhibition of thyroid hormone synthesis, an increase in thyrotropin (TSH). |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
Mycophenolate mofetil (MMF) embryopathy is a malformative syndrome due to the teratogenic effect of MMF, an effective immunosuppressive agent widely used for the prevention of organ rejection after organ transplantation. |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
A teratogenic embryofetopathy that results from maternal exposure to methimazole (MMI; or the parent compound carbimazole) in the first trimester of pregnancy. MMI is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, MMI may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short upslanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia/hypothelia. |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|
A rare teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 20%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies. |
Is a |
False |
Congenital malformation syndrome due to known exogenous cause |
Inferred relationship |
Some |
|